Literature DB >> 19682929

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Caroline E Sutton1, Stephen J Lalor, Cheryl M Sweeney, Corinna F Brereton, Ed C Lavelle, Kingston H G Mills.   

Abstract

Th17 cells, CD4(+) T cells that secrete interleukin-17 (IL-17), are pathogenic in autoimmune diseases and their development and expansion is driven by the cytokines IL-6, TGF-beta, IL-21, IL-1, and IL-23. However, there are also innate sources of IL-17. Here, we show that gammadelta T cells express IL-23R and the transcription factor RORgammat and produce IL-17, IL-21, and IL-22 in response to IL-1beta and IL-23, without T cell receptor engagement. IL-17-producing gammadelta T cells were found at high frequency in the brain of mice with experimental autoimmune encephalomyelitis (EAE). gammadelta T cells activated by IL-1beta and IL-23 promoted IL-17 production by CD4(+) T cells and increased susceptibility to EAE, suggesting that gammadelta T cells act in an amplification loop for IL-17 production by Th17 cells. Our findings demonstrate that gammadelta T cells activated by IL-1beta and IL-23 are an important source of innate IL-17 and IL-21 and provide an alternative mechanism whereby IL-1 and IL-23 may mediate autoimmune inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682929     DOI: 10.1016/j.immuni.2009.08.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  690 in total

Review 1.  gammadelta T cell subsets: a link between TCR and function?

Authors:  Rebecca L O'Brien; Willi K Born
Journal:  Semin Immunol       Date:  2010-05-06       Impact factor: 11.130

Review 2.  Beyond alphabeta/gammadelta lineage commitment: TCR signal strength regulates gammadelta T cell maturation and effector fate.

Authors:  Sandra M Hayes; Renee M Laird; Paul E Love
Journal:  Semin Immunol       Date:  2010-05-08       Impact factor: 11.130

3.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 4.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

5.  Macrophages participate in IL-17-mediated inflammation.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; Sufey Ong; Farhan Quader; Ping Chen; Dongfeng Zheng; Patrizio Caturegli; Noel R Rose; Daniela Ciháková
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

6.  Vγ4+ T cells regulate host immune response to West Nile virus infection.

Authors:  Thomas Welte; Judith Aronson; Bin Gong; Aparna Rachamallu; Nicole Mendell; Robert Tesh; Slobodan Paessler; Willi K Born; Rebecca L O'Brien; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11

7.  CCL20, γδ T cells, and IL-22 in corneal epithelial healing.

Authors:  Zhijie Li; Alan R Burns; Sarah Byeseda Miller; C Wayne Smith
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

8.  Choroidal γδ T cells in protection against retinal pigment epithelium and retinal injury.

Authors:  Zhenyang Zhao; Yuejin Liang; Yin Liu; Pei Xu; Miles J Flamme-Wiese; Deming Sun; Jiaren Sun; Robert F Mullins; Yan Chen; Jiyang Cai
Journal:  FASEB J       Date:  2017-07-20       Impact factor: 5.191

Review 9.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

Review 10.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.